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Background. Changes in the phenotype and function of Mycobacterium tuberculosis (M. tuberculosis)-speciﬁc
CD4+ and CD8+ T-cell subsets in response to stage of infection may allow discrimination between active tuberculo-
sis and latent tuberculosis infection.
Methods. A prospective comparison of M. tuberculosis-speciﬁc cellular immunity in subjects with active tuber-
culosis and latent tuberculosis infection, with and without human immunodeﬁciency virus (HIV) coinfection. Poly-
chromatic ﬂow cytometry was used to measure CD4+ and CD8+ T-cell subset phenotype and secretion of interferon
γ (IFN-γ), interleukin 2 (IL-2), and tumor necrosis factor α (TNF-α).
Results. Frequencies of CD4+ and CD8+ cells secreting IFN-γ-only, TNF-α-only and dual IFN-γ/TNF-α were
greater in active tuberculosis vs latent tuberculosis infection. All M. tuberculosis-speciﬁc CD4+ subsets, with the ex-
ception of IL-2-only cells, switched from central to effector memory phenotype in active tuberculosis vs latent
tuberculosis infection, accompanied by a reduction in IL-7 receptor α (CD127) expression. The frequency of PPD-
speciﬁc CD4+ TNF-α-only-secreting T cells with an effector phenotype accurately distinguished active tuberculosis
from latent tuberculosis infection with an area under the curve of 0.99, substantially more discriminatory than mea-
surement of function alone.
Conclusions. Combined measurement of T-cell phenotype and function deﬁnes a highly discriminatory bio-
marker of tuberculosis disease activity. Unlocking the diagnostic and monitoring potential of this combined ap-
proach now requires validation in large-scale prospective studies.
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The high proportion of the global tuberculosis burden
among those with human immunodeﬁciency virus
(HIV) coinfection results in poor individual and
population level outcomes due to increased susceptibil-
ity, morbidity, and mortality [1]. Mycobacterium tuber-
culosis (M. tuberculosis) induces several conventional
and unconventional T-cell subsets, but the predominant
response is mediated by classically restricted, peptide-
speciﬁc Th1 type CD4+ T cells and CD8+ cytotoxic T
lymphocytes (CTLs), which are essential for protective
immunity in murine models of tuberculosis [2]. HIV
and active tuberculosis both impact M. tuberculosis-
speciﬁc T-cell immunity, as evidenced by the phenome-
non of skin test anergy and impaired cellular immunity
in those with active tuberculosis without HIV coinfec-
tion [3] and HIV coinfected individuals [4]. Dissecting
out the effects of tuberculosis stage and HIV infection is
thus necessary to delineate the potential roles of distinct
T-cell subsets as biomarkers of active tuberculosis and
latent tuberculosis infection.
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Functional CD4+ and CD8+ T-cell subsets have been deﬁned
based on single-cell cytokine (interferon γ [IFN-γ]/interleukin
2 [IL-2]/tumor necrosis factor α [TNF-α]) signatures. These
are differentially impacted by disease stage, mycobacterial load,
and treatment [5–7], suggesting that certain subsets may serve
as biomarkers of disease activity, pathogen burden, or treat-
ment response. However, evidence to date is limited by a
paucity of data on the cell surface marker phenotype of these
subsets in M. tuberculosis infection, which is key to characteriza-
tion of T cells, denoting memory status, disease site homing, sur-
vival, and activation [8]. Changes in dominant functionally
deﬁned memory response have been associated with varying
antigen load in other disease models [9, 10], and studies suggest
that M. tuberculosis-speciﬁc cells present in active tuberculosis
are predominantly of effector-memory phenotype [11–13].
However, further work is needed to conﬁrm and further under-
stand how memory and activation phenotype relates to tubercu-
losis disease stage [6] and HIV coinfection.
Previous data indicated that measurement of CD4+ M. tuber-
culosis-speciﬁc TNF-α-only secreting cells might serve as an
accurate biomarker of active tuberculosis [14]. We hypothe-
sized that measuring both M. tuberculosis-speciﬁc T-cell func-
tion and phenotype would reﬁne this approach and reveal more
discriminatory biomarker(s). Therefore, we performed multi-
parameter ﬂow cytometry for 3 canonical cytokines and key
markers of memory and activation in subjects distinguished by
mycobacterial load (active tuberculosis vs latent tuberculosis
infection) and HIV status. This enabled simultaneous deﬁni-
tion of functional and phenotypic M. tuberculosis-speciﬁc
T-cell proﬁles at the single-cell level. Studying precisely deﬁned
patient groups enabled us to dissect out the inﬂuence of myco-
bacterial load and HIV coinfection on M. tuberculosis-speciﬁc
cellular immunity to tease out which functional and phenotypic
subsets could serve asmarkers ofmycobacterial pathogenburden
independently of HIV coinfection status.
METHODS
Participants were prospectively enrolled from 3 clinical centers in
London, during the period January 2008–February 2011 under
National Research Ethics Service approval (07/H0712/85). Partic-
ipants were ≥18 years, provided written, informed consent, and
were eligible if under clinical investigation for active tuberculosis,
undergoing latent tuberculosis infection screening, or had recog-
nized tuberculosis risk factors (eg, known tuberculosis contact).
Suspected active tuberculosis was conﬁrmed microbiologi-
cally by the clinical diagnostic laboratory. Latent tuberculosis
infection was deﬁned as a positive response to RD-1 antigens in
either T-SPOT.TB (carried out in routine clinical work up) or
M. tuberculosis IFN-γ ELISpot (carried out for the current
study) in the absence of symptomatic, microbiological, or ra-
diological evidence of active tuberculosis.
Presence of HIV infection was conﬁrmed by third or fourth
generation sero-assay performed by the clinical diagnostic labora-
tory and using HIV-1 type speciﬁc enzyme immunoassay (EIA),
according to national standards. HIV viral load (VL) and CD4 T-
lymphocyte counts were assayed in the local Clinical Pathology
Association-accredited diagnostic laboratories at the time of
study recruitment. HIV diagnostics were available for all patients
with active tuberculosis (in line with the national screening
policy) and the majority of those with latent tuberculosis infec-
tion; the remainder had no risk factors for HIV and normal CD4:
CD8 lymphocyte ratios and were classiﬁed as HIV-uninfected.
IFN-γM. tuberculosis ELISpot
Fresh or frozen peripheral blood mononuclear cells (PBMCs),
2.5 × 105 per well, were stimulated overnight (37°C, 5% CO2, 16–
20 hours) in an IFN-γ ELISpot plate (Mabtech) with phytohemag-
glutinin (PHA; positive control; Sigma-Aldrich), Tuberculin
Puriﬁed Protein Derivative (PPD; Statens Serum Institute) or pools
of M. tuberculosis-speciﬁc 15-mer overlapping peptides covering
each of ESAT-6, CFP-10, EspC, TB7.7, Rv3879c, Rv3873, and
Rv3878. Unstimulated cells were used as a negative control. The
IFN-γ ELISpot assay was performed as described elsewhere [15].
Intracellular Cytokine Staining and Polychromatic Flow
Cytometry
Thawed PBMCs (3–5 × 106 per well) were cultured for 16
hours (37°C, 5% CO2) in 10% human serum (Sigma–Aldrich)
in RPMI-1640 (Sigma-Aldrich) at a concentration of 1 × 107
cells/mL. Cells were stimulated with PMA-Ionomycin (positive
control) (Sigma–Aldrich; ﬁnal concentration of 5ng/ml for
PMA and 500ng/ml for Ionomycin), PPD (16.7 μg/mL ﬁnal
concentration), or a cocktail of peptides spanning the length of
3 highly immunodominant M. tuberculosis-speciﬁc RD1-
associated antigens, ESAT-6, CFP-10, and EspC (10 µg/mL
ﬁnal concentration per peptide) [16]. Unstimulated cells were
used as a negative control. After 2 hours, monensin (2 μM ﬁnal
concentration) was added. Following stimulation, cells were
washed and stained with a dead cell marker (LIVE/DEAD
Fixable Dead Cell Stain Kits, aqua, Invitrogen) for 30 minutes
at 4°C in phosphate-buffered saline (PBS). Cells were then
washed in PBS and placed in FC block buffer (10% human serum
in ﬁltered FACS solution [0.5% bovine serum albumin and 2 mM
EDTA in PBS]) for 20 minutes at 4°C before staining with a pre-
titrated and optimized antibody cocktail with ﬂuorochrome-
conjugated antibodies against CD3-APC-Alexa Fluor750,
CD4-Qdot605, CD45RA-Qdot655 (Invitrogen), CD8-APC,
CCR7-PE-Cy7, CD127-FITC (BD Biosciences), and PD-1-
PerCP/Cy5.5 (Biolegend). After washing, the cells were ﬁxed
and permeabilized using BD Cytoﬁx/Cytoperm Fixation/Per-
meabilization kit (BD Biosciences) for 20 minutes at 4°C. The
cells were washed twice with Perm/Wash solution (BD Biosci-
ences) then stained with pre-titrated ﬂuorochrome-conjugated
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antibodies in Perm/Wash solution with IFN-γ-V450, IL-2-PE,
and TNF-α-AlexaFluor 700 (BD Biosciences) for 30 minutes at
4°C. 1 × 106 events (where possible) were acquired straightaway
using a BD LSR-II ﬂow cytometer. Anti-Rat and Anti-Mouse Ig
compensation beads (BD Biosciences) were used to set com-
pensation parameters. Fluorescence minus one (FMO) controls
were used in each experiment to set gates.
Data Analysis and Thresholds
The data were analyzed on FlowJo version 9.4.4,TreeStar, Inc.
Events were gated on live cells, singlets, and lymphocytes using
forward and side scatter properties. CD3+CD4+ and CD3+ CD8+
subsets were deﬁned. Gating controls were used to deﬁne IFN-γ,
IL-2, and TNF-α responses and surface marker expression.
For phenotypic analysis of M. tuberculosis-speciﬁc cells,
only participants with a positive response were included. Posi-
tive responders were deﬁned as those with a response that was
≥2 times the background (in unstimulated but fully stained
samples) and >0.001% of CD3+CD4+ or CD3+CD8+ cells. This
cutoff was used because we did not use costimulation to
enhance responses, and we normalized to background (unsti-
mulated) data before applying the cutoff (rather than classifying
background as negligible). A strict cutoff meant only antigen-
speciﬁc cells were included in the phenotypic analysis.
Statistical Analysis
Statistical analysis was conducted using IBM SPSS Statistics
version 20 and GraphPad Prism version 5.00 for Mac OS X,
GraphPad Software, California. Tuberculosis disease stage com-
pared all tuberculosis (n = 13) vs all latent tuberculosis infection
(n = 21) regardless of HIV status, the impact of HIV compared
all HIV-infected (n = 17) vs uninfected (n = 17) regardless of tu-
berculosis disease stage and across all 4 subgroups. The 2-tailed
Mann–Whitney U test was used for nonparametric 2-sample
comparisons. Spearman rank correlation coefﬁcients were used
to test correlations. Receiver operator characteristic (ROC)
curve deﬁned the sensitivity and speciﬁcity of the diagnostic
approach.
RESULTS
Study Population
Demographic characteristics of the study population are shown
in Table 1.
Table 1. Demographics and Clinical Test Results of Participants
HIV/Tuberculosis Tuberculosis
HIV/Latent
Tuberculosis
Infection
Latent
Tuberculosis
Infection Total
7 (%) 6 (%) 10 (%) 11 (%) 34 (%)
Median (IQR) age 43 (40.5–52.4) 34.5 (28.0–56.0) 36 (24.0–39.0) 33 (31.0–35.5) 35.5 (31.3–40.8)
Sex
Male 4 (57.1) 3 (50.0) 6 (60.0) 4 (36.4) 17 (50.0)
Female 3 (42.9) 3 (50.0) 4 (40.0) 7 (63.6) 17 (50.0)
Ethnicity
Black 5 (71.4) 1 (16.7) 8 (80.0) 6 (54.5) 20 (58.8)
Asian 1 (14.3) 3 (50.0) 0 (0.0) 3 (27.3) 7 (20.6)
White 1 (14.3) 2 (33.3) 2 (20.0) 2 (18.2) 7 (20.6)
BCG vaccination
yes 5 (71.4) 3 (50.0) 9 (90.0) 8 (72.7) 25 (73.5)
no 1 (14.3) 2 (33.3) 0 (0.0) 2 (18.2) 5 (14.7)
unknown 1 (14.3) 1 (16.7) 1 (10.0) 1 (9.1) 4 (11.8)
Microbiological (smear/culture) confirmation
positive 7a (100.0) 6a (100.0) NA NA NA NA 13 (100.0)
negative 0 (0.0) 0 (0.0) NA NA NA NA 0 (0.0)
HIV test
positive 7 (100.0) 0 (0.0) 10 (100.0) 0 (0.0) 17 (50.0)
negative 0 (0.0) 6 (100.0) 0 (0.0) 6 (54.5) 12 (35.3)
not done 0 (0.0) 0 (0.0) 0 (0.0) 5b (45.5) 5 (14.7)
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; NA, not applicable.
All subjects tested positive in one or more of the tuberculin skin test, TSPOT.TB, QuantiFERON-TB Gold In-Tube or M. tuberculosis IFN-γ ELISpot, performed
clinically or for the current study.
a 10 patients with tuberculosis had not started treatment at the point of recruitment, 2 had received <14 days treatment, and 1 had received ≥14 days treatment.
b All participants without clinical need for HIV testing had normal CD4:CD8 ratios.
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The Frequency of CD4+ and CD8+ Cells With an IFN-γ+ and
TNF-α+ Response Was Increased in Active Tuberculosis
We ﬁrst examined the frequency of CD4+ and CD8+ functional
effector cell subsets. Boolean gating was used to create individual
nonoverlapping subsets by combining data in 3 dimen-
sions (Figure 1A). The frequency of PPD-speciﬁc CD4+ IFN-γ
only, TNF-α only, and IFN-γ/TNF-α-dual-secreting cells was
higher in active tuberculosis compared with latent tuberculosis
infection (P = .003, .002, and .002, respectively; Figure 1B). A
similar relationship was seen for RD1-peptide-specifc CD4+
IFN-γ-only-secreting cells (not signiﬁcant; data not shown),
and IFN-γ/TNF-α-dual-secreting cells (P = .017; Figure 1B).
The presence of HIV infection was not associated with an
altered frequency of these cell subsets. We observed no dif-
ference in the frequency of trifunctional cells in patients with
active tuberculosis compared with those with latent tuberculo-
sis infection (Supplementary Figure 1).
The majority of participants with active tuberculosis, but not
latent tuberculosis infection, had a CD8+ IFN-γ response (PPD:
12/13 for active tuberculosis vs 6/21 for latent tuberculosis
Figure 1. Frequency of IFN-γ and TNF-α secreting CD4+ and CD8+ cell subsets are increased in active tuberculosis. A, Example gating strategy for the
CD4+ TNF-α-only-secreting subset using representative plots from an individual with active tuberculosis whose cells were stimulated overnight with PPD
is shown. Cells were gated on live singlets (not shown) and CD3 + CD4+ cells (top row), then according to IFN-γ, IL-2, and TNF-α expression using FMOs
(middle row ). Boolean gating was used to deﬁne individual nonoverlapping functional subsets, eg, the TNF-α-only subset which did not express IFN-γ or
IL-2 (bottom row ). Graphs show frequency and median of CD4+ (B ) and CD8+ (C ) cells secreting IFN-γ and TNF-α in response to overnight stimulation with
PPD or RD1-peptides in participants with active tuberculosis vs latent tuberculosis infection. Those with HIV coinfection (ﬁlled circles) and without HIV
coinfection (open circles) are indicated. Results were analyzed by Mann–Whitney U test; and P values of < .05 were considered signiﬁcant. Abbreviations:
HIV, human immunodeﬁciency virus; IFN, interferon; IL, interleukin; PPD, puriﬁed protein derivative; TNF, tumor necrosis factor.
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Figure 1 continued.
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Figure 2. Cell surface phenotype of CD4+ cell functional subsets is inﬂuenced by tuberculosis disease stage: CD4+ cell functional subsets were examined
for CD45RA and CCR7 expression in active vs latent tuberculosis infection in those with a positive response. A, An example gating strategy for a PPD-speciﬁc
CD4+ IFN-γ-only secreting subset is demonstrated using representative plots from an individual with active tuberculosis. Each CD3 + CD4+ (top row) functional
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infection, RD1-peptides: 10/13 for active tuberculosis vs 11/21 for
latent tuberculosis infection). The frequencies of PPD- and
RD1-peptide-speciﬁc CD8+ IFN-γ-only producing cells were sig-
niﬁcantly higher in active tuberculosis than in latent tuberculosis
infection (P = .017 and .016, respectively), as was the frequency of
CD8+ PPD-speciﬁc cells secreting both IFN-γ and TNF-α
(P = .013; Figure 1C). HIV coinfection was (nonsigniﬁcantly) as-
sociated with a reduced frequency of PPD-speciﬁc IFN-γ/TNF-
α-dual andTNF-α-only responses in active tuberculosis compared
with HIV negativity (P = .051 for both). In the HIV-uninfected
tuberculosis group the percentages of these PPD-speciﬁc CD8+
cells were signiﬁcantly higher than in latent tuberculosis infection
(P = .008 and .022, respectively). Similarly, the frequency of cells
secreting IFN-γ-onlywere signiﬁcantly higher in active tuberculosis
compared with latent tuberculosis infection in HIV-uninfected
(P = .023). These CD8+ effector functional subsets were therefore
Figure 2 continued. subset, eg, IFN-γ-only-secreting cells (middle row) was analyzed for expression of CD45RA and CCR7 (bottom row). B, Graphs show
the percentage (and median percentage) of PPD-stimulated CD4+ IFN-γ-only (top row), TNF-α-only (middle row), and IL-2-only (bottom row) cells that were
CD45RA-CCR7+ (TCM) (left column) and CD45RA-CCR7- (TEM) (right column) in patients with active tuberculosis and latent tuberculosis infection. The top 2
rows are representative of changes observed in active vs latent tuberculosis infection in all M. tuberculosis-speciﬁc (responding to PPD and RD-1-peptides)
CD4+ functional subsets except IL-2-only-secreting cells. Those with HIV coinfection (ﬁlled circles) and without HIV coinfection (open circles) are indicated.
Results were analyzed by Mann–Whitney U test; and P values of < .05 were considered signiﬁcant. Abbreviations: HIV, human immunodeﬁciency virus;
IFN, interferon; IL, interleukin; M. tuberculosis, Mycobacterium tuberculosis; PPD, puriﬁed protein derivative; TNF, tumor necrosis factor.
Figure 3. Percentage of M. tuberculosis-speciﬁc CD4+ functional T-cell subsets expressing CD127 is inﬂuenced by stage of tuberculosis infection and
CD4 count: CD3 + CD4+ functional cell subsets were examined for CD127 expression. A, A representative gating strategy is shown. PBMCs from an individ-
ual with latent tuberculosis infection infection were stimulated overnight with PPD, and CD3 + CD4+ cells (top row) were gated for cytokine secretion, eg,
IFN-γ-only-secreting subset (middle row) and analyzed for expression of CD127 (bottom row).
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related to mycobacterial load analogously to equivalent CD4+
subsets, but the impact of HIV coinfection was more profound.
PPD-speciﬁc and RD1-peptide-speciﬁc CD4+ Cellular
Differentiation Was Increased in Active Tuberculosis vs
Latent Tuberculosis Infection
We analyzed the memory phenotype of the CD4+ functional
subsets as putative correlates of mycobacterial pathogen load.
Nonresponders were excluded. Each T-cell functional subset
was gated for expression of CD45RA and CCR7 (Figure 2A).
Memory phenotypes of functional subsets were deﬁned as
naive CD45RA + CCR7+, central memory (TCM) CD45RA
−
CCR7+, effector memory (TEM) CD45RA
−CCR7− and
CD45RA+ effectors (TEMRA) CD45RA
+ CCR7−. This last subset
was mainly evident in CD8+ cells.
PPD- and RD1-peptide-speciﬁc CD4+ cell effector function-
al subsets were principally TCM in latent tuberculosis infection
compared to TEM in active tuberculosis, for example, fewer
PPD-speciﬁc CD4+ IFN-γ-only secreting cells were TCM in
active tuberculosis compared with latent tuberculosis infection
(P = .005; Figure 2B). Comparisons of HIV-infected with unin-
fected patients were nonsigniﬁcant except for the CD4+ RD1-
peptide-speciﬁc IFN-γ-only- and TNF-α/IL-2-dual-secreting
subsets, fewer of which were TCM in HIV-infected than unin-
fected subjects (P = .030 and .006; Supplementary Figure 2).
In contrast to the CD4+ effector functional subsets, CD4+ IL-
2-only PPD- (Figure 2B) and RD1-peptide-speciﬁc cells (data
not shown) were principally TCM in both active tuberculosis
and latent tuberculosis infection and were therefore unaffected
by tuberculosis disease stage. CD8+ IFN-γ-only cellular re-
sponses to PPD and RD1-peptides were mostly TEM and
TEMRA (data not shown).
CD127 (IL7Rα) expression is reduced following antigen stimu-
lation in effector T cells [17] and deﬁnes CD4+ and CD8+ subsets
Figure 3 continued. B, Graphs show percentage (and median percentage) of cells expressing CD127 from positive responders in CD4+ IFN-γ-only- (top
row), TNF-α-only- (middle row), and IFN-γ- and TNF-α-dual-secreting (bottom row) cell subsets following stimulation with PPD (left column) and RD1-
peptides (right column) in active tuberculosis and latent tuberculosis infection. Patients with HIV coinfection (ﬁlled circles) and without HIV coinfection
(open circles) are indicated. Results were analyzed by Mann–Whitney U test; and P values of < .05 were considered signiﬁcant.
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of differentiated murine T effector cells distinct from effector
memory cells [18, 19].We therefore measured CD127 expression
on antigen-speciﬁc CD4+ functional T-cell subsets (Figure 3A). A
smaller percentage of PPD- and RD1-peptide-speciﬁc CD4+ cells
expressed CD127 in active tuberculosis compared with latent
tuberculosis infection, for example, a lower percentage of
PPD-speciﬁc CD4+ IFN-γ-only- and TNF-α-only-secreting cells
expressed CD127 in active tuberculosis compared with latent tu-
berculosis infection (P < .001 and P = .003, respectively; Figure 3B).
Expression of CD127 on antigen-speciﬁc cells was unaffected by
HIV status (Figure 3B). However, in patients withHIV coinfection,
frequencies of several subsets of PPD-speciﬁc T cells expressing
CD127 correlated with CD4 count (Figure 3C). Similarly, for
RD-1-peptide-speciﬁc cells, IFN-γ/IL-2-dual-producing cells ex-
pressing CD127 correlated with CD4 count (ρ = 0.647; P = .047)
and HIV VL correlated inversely with IFN-γ-only (ρ =−0.780;
P = .013) and IFN-γ/TNF-α-dual-secreting CD127-expressing
cells (ρ =−0.727; P = .005; data not shown).
Expansion of Differentiated CD4+ Functional Effector T Cells in
Active Tuberculosis vs Latent Tuberculosis Infection
We next investigated the potential of combined phenotypic and
functional measurement as a clinical biomarker. We determined
the percentage of PPD- and RD1-peptide-speciﬁc CD4+ cells
secreting IFN-γ-only or TNF-α-only that were differentiated
effector cells (TEFF; CD45RA-CCR7-CD127-; Figure 4A [active
tuberculosis] and B [latent tuberculosis infection]). In active
tuberculosis, compared with latent tuberculosis infection, a
higher percentage of CD4+ cells secreting IFN-γ-only or TNF-
α-only in response to PPD and RD1-peptides were TEFF. This
was most signiﬁcant for CD4+ PPD-speciﬁc CD4+ cells secret-
ing TNF-α-only (P < .0001) and IFN-γ-only (P < .0001). A
cutoff of 17.3% of TNF-α-only cells of TEFF phenotype distin-
guished active tuberculosis from latent tuberculosis infection
with 100% sensitivity (95% CI, 73.5–100.0) and 92.9% speciﬁc-
ity (95% CI, 66.1–99.8; Table 2). In ROC analysis, area under
the curve was 0.99 (95% CI, .97–1.01; P < .0001; Figure 4C).
Similar, although slightly less discriminatory ROC curves were
generated for PPD-speciﬁc IFN-γ-only cells and for RD-1-
speciﬁc cells (Figure 4C).
To test whether this approach was robust to differences in
disease site, we compared individuals with active pulmonary and
extrapulmonary disease. We found no signiﬁcant difference in
the proportion of PPD-speciﬁc cells secreting IFN-γ-only, or
TNF-α-only that were TEFF (Figure 4D) when stratiﬁed by site of
disease or HIV coinfection. There was also no difference in the
proportion of RD-1 peptide-speciﬁc cells that were TEFF when
stratiﬁed by disease site (data not shown).
The operator conducting analyses (KMP) was also involved in
participant recruitment and therefore not blinded to patient
Figure 3 continued. C, Graphs show correlations of CD4 cells/µL with the percentage of CD4+ PPD-speciﬁc cells secreting all 3 cytokines (top left), IFN-γ-
only (top right), TNF-α and IL-2 (bottom left), and TNF-α only (bottom right) that expressed CD127 in patients with HIV coinfection. Patients with tuberculo-
sis (open circles) and latent tuberculosis infection (ﬁlled circles) are indicated. Spearman’s rank correlation coefﬁcient, corresponding P values, and lines of
best ﬁt are shown. Abbreviations: HIV, human immunodeﬁciency virus; IFN, interferon; IL, interleukin; M. tuberculosis, Mycobacterium tuberculosis; PPD,
puriﬁed protein derivative; TNF, tumor necrosis factor.
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categorization. To demonstrate integrity and reproducibility of the
results, data for all study participants were regated and reanalysed
by a second independent operator (HSW) who was blinded
to patient diagnoses. Correlations between results obtained by op-
erators 1 and 2 for the percentage of CD3 + CD4+ cells secreting
TNF-α-only (ρ = 0.97, P < .0001), the percentage of CD3 + CD4+
TNF-α-only-secreting cells that are CD127+ (ρ = 0.96, P < .0001)
and the percentage of CD3 + CD4+ TNF-α-only-secreting cells
that are CD45RA−CCR7− (ρ = 0.88, P < .0001) were very strong.
Using the 17.3% cutoff for TNF-α-only-secreting cells of TEFF
phenotype to distinguish tuberculosis from latent tuberculosis in-
fection, operator 2 misclassiﬁed 1 case of tuberculosis as latent
Figure 4. Combining functional subset analysis with memory phenotype reveals a potentially powerful biomarker to distinguish active and latent tuber-
culosis infection. Boolean gating was used to analyze the percentage of PPD-speciﬁc CD4+ TNF-α-only-secreting cells that had the phenotype TEFF
(CD45RA-CCR7-CD127-) in active and latent tuberculosis infection. A representative gating strategy is shown for individuals with active tuberculosis (A)
and latent tuberculosis infection (B).
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tuberculosis infection, and 1 further case of latent tuberculosis in-
fection as tuberculosis (data not shown).
DISCUSSION
Our detailed interrogation of antigen-speciﬁc T-cell phenotype
and function has delineated the association of tuberculosis
disease stage with M. tuberculosis-speciﬁc cellular immunity.
active tuberculosis was associated with an increased frequency
of mono- or dual-functional CD4+ and CD8+ M. tuberculosis-
speciﬁc T cells that secrete IFN-γ and/or TNF-α making these
subsets potential biomarkers of disease activity.
Measurement of the proportion of TNF-α-only secreting
M. tuberculosis-responsive CD4+ cells has proved promising to
distinguish between active tuberculosis and latent tuberculosis
infection [14] but neither earlier data nor our ﬁndings have
Figure 4 continued.
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Figure 4 continued. C, Graphs in the left column show the percentage (and median percentage) of PPD or RD-1 peptide-speciﬁc CD4+ TNF-α-only and
IFN-γ-only cells from responders that were TEFF. Cutoff values for distinguishing active tuberculosis from latent tuberculosis infection are shown as dotted
lines, and corresponding ROC curves are shown in the right column. A cutoff of 17.3% of TNF-α-only cells of TEFF phenotype distinguished active tuberculo-
sis from latent tuberculosis infection with 100% sensitivity (95% CI, 73.5–100.0) and 92.9% speciﬁcity (95% CI, 66.1–99.8) (Table 2). In ROC analysis,
area under the curve was 0.99 (95% CI, .97–1.01; P < .0001) (Figure 4C). A cutoff of 34.5% for PPD-speciﬁc IFN-γ-only cells gave a sensitivity of 100%
(95% CI, 73.5–100.0) and speciﬁcity of 84.2% (95% CI, 60.42–96.6); a cutoff of 33.8% for RD-1-speciﬁc TNF-α-only cells gave a sensitivity of 100% (95%
CI, 54.07–100.0) and speciﬁcity of 75.0% (95% CI, 34.91–96.8); and a cutoff of 49.3% of RD-1-speciﬁc IFN-γ-only cells gave a sensitivity of 100% (95% CI,
66.4–100.0) and speciﬁcity of 75.0% (95% CI, 42.8–94.5).
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clinically sufﬁcient discriminatory power. The slight difference
in our ﬁndings compared with those previously published may
be because we stratiﬁed for HIV infection and tuberculosis
disease stage and we did not use costimulation in our assays.
The use of costimulation may reﬂect the cells’ ability to react to
certain stimuli not necessarily present in vivo, instead of mea-
suring the ability of these cells to respond to antigen. Studies
have suggested that the presence of trifunctional cells secreting
IFN-γ, IL-2, and TNF-α correlates with active tuberculosis [20,
21], but our data did not support this association. Our func-
tional data therefore partially corroborates and extends earlier
observations [6, 14] that measurement of the frequency of M.
tuberculosis-speciﬁc CD4+ effector-like cells secreting IFN-γ
and/or TNF-α can distinguish active tuberculosis from latent
tuberculosis infection.
Simultaneous evaluation of memory phenotype of respond-
ing cells provided a more sensitive and speciﬁc surrogate than
CD4+ functional proﬁle alone. Expression of CD45RA, CCR7,
and CD127 on M. tuberculosis-speciﬁc T cells secreting only
IFN-γ or TNF-α was lowest in those with active tuberculosis.
Interestingly, memory phenotype was not exclusively linked to
the functional proﬁle (except for IL-2-only cells which were
mainly TCM) but was closely related to underlying tuberculosis
stage. These markers might therefore serve as indicators of tu-
berculosis activation. Combined measurement of both func-
tional proﬁle and differentiation phenotype provided a highly
discriminatory immunological read-out for active tuberculosis
and latent tuberculosis infection. In those with active tuberculo-
sis, >17.3% of PPD-speciﬁc CD4+ TNF-α-only-secreting cells
were CD45RA−CCR7−CD127−, and this phenotype was there-
fore strongly associated with activated infection. Given that re-
sponses to PPD are less speciﬁc for M. tuberculosis infection
than responses to RD-1 antigens, this PPD-speciﬁc T-cell sig-
nature may be used to distinguish tuberculosis from latent tu-
berculosis infection in the second step of a 2-step diagnostic
testing strategy, where M. tuberculosis infection has been ruled
in at step one by a positive result in an RD-1-based immunodi-
agnostic test (eg, IGRA).
Memory phenotype of responding cells and association with
tuberculosis stage has previously been evaluated qualitatively
and to some extent quantitatively. Studies have suggested that
changes in the predominant memory phenotype of the re-
sponding CD4+ and CD8+ cells might be dependent on severe
vs nonsevere, or active vs latent tuberculosis in adults and chil-
dren [22–25]. None were able to simultaneously measure the
antigen-speciﬁc function and phenotype of multiple CD4+ and
CD8+ T-cell subsets. Equally these studies did not speciﬁcally
measure cells with the TEFF phenotype, which had lost CD127
expression. Therefore, although the principle was explored,
none identiﬁed a subset that could serve as a highly sensitive
and speciﬁc clinical biomarker.
The frequency of both PPD and M. tuberculosis-speciﬁc
CD8+ functional effectors increased in active tuberculosis and
might therefore also be responding to increased mycobacterial
load, consistent with the observation that these cells respond
more effectively to heavily infected dendritic cells [26]. The fre-
quency of M. tuberculosis-speciﬁc CD8+ cells was increased in
adults with sputum smear-positive pulmonary tuberculosis [6]
and in children with active tuberculosis compared with con-
tacts [27]. Similarly our data showed that the frequency of
CD8+ M. tuberculosis-speciﬁc cells, and therefore proportion
of responders, was increased in active tuberculosis and this ap-
proach holds promise for the discrimination of tuberculosis
disease stage especially in HIV coinfection where all participants
had a positive response to M. tuberculosis peptides. This associa-
tion, shown by us and others [6], precludes the comparison of
combined function and phenotype of M. tuberculosis-speciﬁc
CD8+ cells, however, because nonresponders were by default
mainly in the latent tuberculosis infection group. Measurement
of CD8+ functional subsets in active tuberculosis and latent
Figure 4 continued. D, Graphs show the percentage (and median percentage) of PPD-speciﬁc CD4+ TNF-α-only and IFN-γ-only cells that were TEFF in pa-
tients with extrapulmonary tuberculosis (ETB) and pulmonary tuberculosis (PTB). Patients with HIV coinfection (ﬁlled circles) and without HIV coinfection
(open circles) are indicated. Results were analyzed by Mann–Whitney U test; and P values of < .05 were considered signiﬁcant. Abbreviations: CI, conﬁ-
dence interval; HIV, human immunodeﬁciency virus; IFN, interferon; IL, interleukin; PPD, puriﬁed protein derivative; TNF, tumor necrosis factor.
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Table 2. Clinical and Radiological Characteristics of Cases Sorted by Percentage of TNF-α-only-Secreting Cells That Were TEFF (CD45RA
−CCR7−CD127−)
No.
%TEFF/TNF-α
only HIV CD4 VL
Sputum
smear
M. tuberculosis
culture Culture site Radiology (CXR or CT)
Tuberculosis final
diagnosis
S135 78.9 Pos 190 281 671 Neg Pos BAL and pleural fluid Bilateral pleural effusions, lung and splenic
nodules, peritoneal thickening
Pulmonary
S126 75.0 Pos 69 601 000 Pos Pos Sputum Azygos lobe focal consolidation in cavity,
pleural effusions, no lymphadenopathy
Pulmonary
S221 72.4 Neg NA NA NT Pos Lymph node Enlarged low density lymph nodes in
mediastinum and left axilla
Extra pulmonary
S059 46.9 Pos 140 <100 Pos Pos Sputum and BAL Effusion, thickened pleura, loss of volume
left lung, ground glass change
Pulmonary
S184 40.5 Neg NA NA NT Pos Lymph node Multiple mediastinal, coeliac axis lymph
nodes with nodules in spleen and breast
Extra pulmonary
S193 37.6 Pos 136 28 958 NT Pos Lymph node Axillary, para-aortic, and abdominal
lymphadenopathy, subpleural nodules,
liver lesions
Extra pulmonary
S083 30.0 Neg NA NA Neg Pos Lymph node, BAL,
peritoneal
Right pleural collection and right paratracheal
lymphadenopathy
Pulmonary
S076 29.2 Pos 200 <50 Pos Pos Left upper lobe, BAL,
sputum
Consolidation and cavitation upper lobe,
interstitial opacities, linear atelectasis
Pulmonary
S115 28.6 Neg NA NA NT Pos Lymph node Mediastianal lymphadenopathy Extra pulmonary
S146 20.1 Pos 250 52 205 NT Pos Lymph node Supraclavicular, mediastinal, and abdominal
lymphadenopathy, nodular infiltrates
Extra pulmonary
S195 18.0 Neg NA NA Pos Pos BAL and lymph node Mediastinal, hilar, and supraclavicular lymph
nodes, patchy consolidation
Pulmonary
S153 17.8 Neg NA NA NT NT NT Nil of note Latent tuberculosis
infection
S082 17.5 Neg NA NA Neg Pos Lymph node Nil of note Extra pulmonary
S074 17.1 Neg NA NA Neg M fortuitum BAL Opacification right upper lobe, small volume
axillary, and mediastinal lymph nodes
Latent tuberculosis
infection
S050 16.7 Pos 480 12 479 NT NT NT Nil of note Latent tuberculosis
infection
S052 13.3 Pos 520 45 719 Neg Neg Sputum Nil of note Latent tuberculosis
infection
S177 12.8 Neg NA Na NT NT NT Nil of note Latent tuberculosis
infection
S094 10.9 Pos 660 <50 NT NT NT Heavily calcified nodule and small lymph
nodes right upper lobe
Latent tuberculosis
infection
S092 10.3 NT NA NA NT NT NT Nil of note Latent tuberculosis
infection
S145 9.4 Neg NA NA NT NT NT NT Latent tuberculosis
infection
S098 8.6 Neg NA NA NT NT NT (Fractured ribs T4–9 posteriorly) Latent tuberculosis
infection
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Table 2 continued.
No.
%TEFF/TNF-α
only HIV CD4 VL
Sputum
smear
M. tuberculosis
culture Culture site Radiology (CXR or CT)
Tuberculosis final
diagnosis
S047 8.5 Pos 360 <50 NT NT NT Nil of note Latent tuberculosis
infection
S079 6.2 NT NA NA NT NT NT Nil of note Latent tuberculosis
infection
S001 5.9 Pos 430 775 NT NT NT Nil of note Latent tuberculosis
infection
S099 5.8 NT NA NA NT NT NT Nil of note Latent tuberculosis
infection
S120 4.7 NT NA NA NT NT NT Fibrosis both apices, hilar lymphadenopathy,
pleural thickening
Latent tuberculosis
infection
S097 NA Pos 177 19 906 Pos Neg Sputum Subcarinal and axillary lymph nodes Pulmonary
S029 NA Pos 530 <50 NT NT NT Nil of note Latent tuberculosis
infection
S025 NA Pos 330 <50 NT NT NT Nil of note Latent tuberculosis
infection
S197 NA Pos 210 <50 NT NT NT Nil of note Latent tuberculosis
infection
S201 NA Neg NA NA NT NT NT Nil of note Latent tuberculosis
infection
S171 NA Pos 365 <50 NT NT NT Nil of note Latent tuberculosis
infection
S191 NA Pos 530 13 328 NT NT NT NT Latent tuberculosis
infection
S121 NA Neg NA NA NT NT NT Nil of note Latent tuberculosis
infection
Abbreviations: BAL, bronchoalveolar lavage; CT, computerized tomography; CXR, chest x-ray; HIV, human immunodeficiency virus; NA, not applicable; Neg, negative; NT, not tested; Pos, positive; TNF, tumor necrosis
factor; VL, viral load.
Those with >17.3% TEFF/TNF-alpha only cells would be predicted to have active tuberculosis in the original analysis and those below it to have latent tuberculosis infection. Those below the second bold dividing line did
not have a positive TNF-α-only response to purified protein derivative.
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tuberculosis infection was therefore not sufﬁciently discrimina-
tory for active and latent tuberculosis infection in our cohort.
In this study we included individuals with HIV coinfection to
compare and distinguish the impact of active tuberculosis on M.
tuberculosis-speciﬁc cellular immunity with the impact of HIV
coinfection. Where CD4+ M. tuberculosis-speciﬁc effector-like
cells were inﬂuenced by tuberculosis disease stage, the impact of
HIV coinfection per se was rarely signiﬁcantly associated with
these changes. This may have been partially due to the inclusion
of patients who were treated for HIV infection. However, in the
case of CD127, stratiﬁcation by CD4 count showed that the stage
of HIV disease inﬂuenced expression of this marker onM. tuber-
culosis-speciﬁc T cells. Reduced CD127 expression on HIV-spe-
ciﬁc CD8+ T cells (reviewed in [28]) and CD4+ T cells [29] is
observed with HIV disease progression, but a relationship
between HIV disease progression and CD127 expression on M.
tuberculosis-speciﬁc T cells has not previously been noted. Our
ﬁnding indicates that in HIV coinfection, M. tuberculosis-
antigen-speciﬁc CD4+ cells lose CD127 expression with advanc-
ing HIV disease and are therefore potentially more differentiated.
This effect could be directly virus-induced or secondary to in-
creasing subclinical mycobacterial burden with advancing HIV
infection.
Our cohort included individuals with both pulmonary and
extra-pulmonary infection. HIV infection is more commonly as-
sociated with tuberculosis dissemination as evidenced by the
widespread involvement in some of these individuals. Despite
some variation in clinical phenotype of those with active tubercu-
losis, our biomarker reliably distinguished tuberculosis stage, re-
gardless of site of disease suggesting that it may remain robust
across the clinical tuberculosis disease spectrum and therefore
have wide applicability. HIV coinfection has recently been shown
to be associated with subclinical active tuberculosis infection in a
tuberculosis endemic area [30]. No individuals with latent tuber-
culosis infection developed active tuberculosis during 12 months
of follow-up suggesting that, in our cohort (recruited in a tuber-
culosis nonendemic area), subclinical tuberculosis was not present
in those classiﬁed as latent tuberculosis infection. The lack of con-
tinuous exogenous priming or restimulation due to tuberculosis
exposure distinguishes our cohort from others recruited from tu-
berculosis endemic areas and removes this is as a possible con-
founding effect on the immunological changes we observed.
It is unknown whether the changes in function and pheno-
type we demonstrated are consequent upon, or causal of, in-
creased disease activity. In a study of tuberculosis contacts there
was no percentage difference in CD4+ or CD8+ memory phe-
notype at baseline in progressors and nonprogressors [31]
arguing against a causal role. Rather, mycobacterial burden
might be driving the dominant functional and phenotypic
changes, strengthening the potential of these markers to serve
as a surrogate of mycobacterial burden. The loss of CCR7, al-
lowing T-cell accumulation at the site of disease [32], and the
loss of CD127, limiting the number and life span of these po-
tentially tissue-destructive cells, may reﬂect an active adaptive
response to replicating mycobacteria. However, given that
immune containment has, by deﬁnition, been lost in active tu-
berculosis, it is equally possible that these T-cell subsets contrib-
ute to tissue pathology, cavitation, and bacillary dissemination.
Limitations of this study included the modest cohort size
and some heterogeneity. Our cohort was sufﬁcient to reveal
powerful positive associations with tuberculosis stage; but a
larger study would be required to conﬁrm the absence of asso-
ciations, for example, between HIV coinfection and frequencies
of certain T-cell subsets. Moreover, because most of our HIV-
infected participants had relatively high CD4 cell counts, our
ﬁndings may be less applicable to more immunosuppressed
HIV-infected patients. Similarly, while our data suggested that
our biomarker was independent of tuberculosis disease site (ie,
pulmonary vs extrapulmonary tuberculosis), a larger sample
size is needed to corroborate this. Such studies could include
other antigens, for example, heparin-binding hemagglutinin
adhesin, that have shown promise in distinguishing active tu-
berculosis from latent tuberculosis infection and risk stratiﬁca-
tion of those with infection [33, 34]
Through dissection of the impact of varying tuberculosis
stage as a surrogate for mycobacterial pathogen burden, with
and without HIV coinfection, we have identiﬁed cellular
changes that are highly sensitive to tuberculosis activity. Future
work will require prospective evaluation of our ﬁndings in an
independent validation cohort, which if corroborative will have
signiﬁcant clinical impact.
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